Noile-Immune Biotech Inc. (4893)
Market Closed
12 Aug, 06:00
JPX JPX Primary ¥
140. 00
-1
-0.7092%
¥
7.01B Market Cap
- P/E Ratio
- Div Yield
27,400 Volume
- Eps
¥ 141
Previous Close Want to track 4893 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Noile-Immune Biotech Inc. (4893) Statistics
Valuation metrics
Market Cap 7.01B
Enterprise value 2.28B
Trailing P/E (ttm) -8.52
Forward P/E -4.41
PEG ratio -0.6
Price/Sales (ttm) 2,216.92
Price/Book (mrq) 1.59
Enterprise Value/Revenue 838.08
Enterprise Value/EBITDA -3.02
Overview
Shares outstanding 43.3M
Float 17M
Shares short -
% Held by insiders 0.58%
% Held by institutions 0.03%
Average volume (10 days) 69.53K
Average volume (90 days) 152.15K
Price summary
52-Week low 114
52-Week high 217
Beta 0.09
50-Day moving average 131.43
200-Day moving average 143.26
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2025
Profitability
Profit margin -260.15%
Operating margin -279.1%
Operational effectiveness
Return on assets -0.18%
Return on equity -0.17%
Income Statement
Revenue (ttm) 3M
Revenue per share (ttm) 0.06
Quarterly revenue growth (yoy) -1%
Gross profit (ttm) -49M
EBITDA -
Net income to common (ttm) -706M
Diluted EPS (ttm) -16.31
Quarterly earnings growth (yoy) -1%
Balance Sheet
Total cash (mrq) 3.74B
Total cash per share (mrq) 86.45
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 62.52%
Book value per share (mrq) 87.26
Cash Flow
Cash flow statement -755.21M
Levered free cash flow (LFCF) -793.54M
